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In contrast for 10 prevention with full efficacy over 10 years, the incremental
C/E is $33,500 per YOLS for men and $35,500 for women. With the full ben-
efit suggested by the epidemiologic studies, the potential years of life saved
in the US from treatment with vit E are:
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All Patients
649 369 1018
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It is generally accepted that a patient with a normal baseline electrocardio-
gram (ECG) should undergo exercise stress testing (EST) to establish the
diagnosis and prognosis of coronary artery disease (CAD), unless standard
EST exclusion criteria are present. Initial evaluation with radionuclide EST
(REST) is an unproven approach that is approximately three times more ex-
pensive than EST alone. The appropriateness and financial ramifications of
REST at an urban university hospital were evaluated during a fourteen month
period.
Patients with clear indications for REST - previously positive EST, prior
myocardial infarction, or previous percutaneous transluminal coronary angio-
plasty - were excluded. REST studies were performed for the diagnosis or
management of CAD in 1902 patients, of whom 975 did not have chest pain.
If the baseline ECG was normal and standard EST exclusion criteria (mitral
valve prolapse, bundle-branch block, significant ST-segment deviation) were
not present, REST was considered not indicated (N-INDI.
EXERCISE PHYSIOLOGY AND TESTING
Non-eardiologists (N-CARD) were more likely than cardiologists (CARD) to
order REST studies in patients without indications for isotopes. Assuming an
excess charge of $11 00 per patient, an unnecessary $1,082,400 was billed in
this population, $409.200 of which was for patients who did not have chest
pain. Assuming a charge of $175 per patient, referral to a cardiologist prior
to REST would have saved $185,260 in this population.
In conclusion, non-cardiologists are more likely to inappropriately order
REST studies than are cardiologists, at a significant excess cost. Although
cardiologists also over utilize REST studies, referral to a cardiologist prior to
testing for CAD may be cost-effective.
treadmill testing (all of which were normal); systolic BP > 170 or diastolic
BP > 110 (n = 5). carotid bruit In = 21, severe AI by exam (n = 1). WPW (n
= 6). PVC's (n = 5). RBBB (n = 4), SVT (n = 1). EKG alone led to disqualifi-
cation in 16 or 1/350 HSA undergoing screening. No cases of hypertrophic
cardiomyopathy or anomalous coronary artery were detected prospectively.
One SCD occurred in an approved HSA due to anomalous coronary artery.
Conclusions: Common causes of SCD in HSA are rare and/or methods to
detect them are insensitive; serious CU abnormalities in this population are
rare; EKG added to the cardiovascular history and physical exam increases
the ability to detect potentially serious abnormalities necessitating further
cardiovascular testing before approval for competitive sports.
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Background. Exercise Training has just recently been recognized as an impor-
tant therapeutic modality in patients with chronic heart failure (CHF). How-
ever, central hemodynamic adaptations to exercise training in patients with
CHF remain unclear.
Methods. Seventeen patients with first diagnosis of CHF (56 ± 5 years,
mean EF ~ 32 ± 6%) were randomized to an exercise raining group (N =
8), or a control group (N = 9). Patients in the exercise group performed two
hours of daily walking along with five sessions per week of high intensity
monitored stationary cycling (40 minutes at 70 to 80% peak capacity) at
a residential rehabilitation center for a period of two months. Control pa-
tients received usual community care. Ventilatory gas exchange and upright
hemodynamic measurements (rest and peak exercise cardiac output, pul-
monary artery, wedge, and mean arterial pressures, and systemic vascular
resistance) were performed before and after the study period.
Results. Changes in oxygen uptake at maximal exercise and the lactate
threshold (LT) were as follows:
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Group Follow-up Actuarial Survival (%)
(months) 5 yrs 10 yrs 15 yrs
LBBB 112 110 ± 67 96 88 81
LBBB Control 112 125 ± 69 99 92 92
RBBB 198 113 ± 71 98 95 90
RBBB Control 198 119 ± 72 99 94 90
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Screening for common causes (hypertrophic cardiomyopathy and anoma-
lous coronary artery) of sudden cardiac death (SCD) in high school athletes
(HSA) during pre-participation exams is varied and relatively unstudied. Ef-
forts to improve diagnoses of potentially serious or lethal congenital heart
conditions are needed. We prospectively evaluated HSA at 34 different high
schools over three years. Cardiovascular screening included obtaining a his-
tory of angina or anginal equivalents, or a family history of SCD before age 35
years. A 12-lead EKG and a cardiovascular physical exam were performed.
Abnormalities resulted in a cardiac ultrasound (CU). Abnormal EKG for LVH
was defined in boys as SVl and RV5 > 50 mm and in girls as SVl plus RV5 >
40 mm. Follow-up of cardiovascular abnormalities followed 16th Bethesda
Conference Guidelines. Results: 5.615 HSA (3378 boys, 2237 girls) were eval-
uated. 115 (2%) had abnormal cardiovascular history, 196 (3.5%) had abnor-
mal cardiovascular exam, 193 (3.5%) had abnormal EKG and 126 (2%) had
combined abnormalities. All 630 (11 %) with abnormal cardiovascular screen-
ing underwent CU at the time of their exam. 43 HSA (7% of CU performed)
were found to have minor abnormalities. No serious previously undetected
abnormality was noted with CU. No LVH was seen in 28 HSA with LVH by
ECG. 5140 (91.5%) HSA were approved for competitive sports; 435 (7.8%1
HSA were approved for competitive sports after follow-up by local M.D. (rec-
ommended primarily for evaluation of mild hypertension); 40 (0.7%) HSA
were not approved due to anginal symptoms (n = 16) requiring subsequent
Background and Methods. The prognostic implications of the incidental dis-
covery of LBBB or RBBB in people without clinically apparent heart disease
remain uncertain. We compared the outcome of 310 such people identified
during screening carried out by The Irish Heart Foundation between 1968
and 1993, and 310 similarly screened age- and sex-matched controls with
similar cardiovascular risk factor profiles.
Results. Persons with isolated LBBB and RBBB constituted 0.1 % and
0.18% respectively, of the screened population After similar follow-up peri-
ods, total actuarial survival (Kaplan-Meier method) was no different for those
with RBBB, LBBB and their respective controls (see table).
Cardiac mortality, however, was increased in the LBBB, but not RBBB,
group when compared to their respective controls (p = 0.01, log-rank test).
At follow-up, overt cardiac disease was evident in 21 % of those with LBBB
compared to 11 % of their controls (p = 0.04). No such difference was ob-
served for those with RBBB.
Conclusions. 1. Isolated LBBB, but not RBBB is associated with an in-
creased long-term cardiac, but not total mortality. 2. Isolated LBBB is a
marker for the subsequent development of clinically overt cardiac disease.
This analysis suggests: 1) For 20 prevention, vit E is worthwhile even if it
causes a 5% or less reduction in CHD. 2) At the above cost over 10 years,
widespread 10 prevention with vit E would be cost-effective only if Vit E is
about as effective as suggested by the cohort studies. 3) If vit E is as effective
as suggested by the above studies (or even 1/8th that for 2' prevention).
then the potential loss of benefit by delaying its use is sufficiently large that
research into the efficacy of Vit E should be a high priority.
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